| RS1592220835 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS1592220915 |
HMBS
|
Health Risk |
Pathogenic/Likely pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS1592221192 |
COL2A1
|
Health Risk |
Likely pathogenic |
COL2A1-related phenotype, COL2A1-related phenotype |
| RS1592221459 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1592221672 |
HMBS
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1592221728 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1592221830 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1592221930 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1592222308 |
ACVRL1
|
Health Risk |
Pathogenic |
Pulmonary arterial hypertension, Cardiovascular phenotype |
| RS1592223028 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1592223392 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Pulmonary arterial hypertension, Pulmonary arterial hypertension |
| RS1592223399 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1592223416 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1592223468 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1592223490 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1592223964 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1592224087 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1592224220 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1592224291 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1592224349 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1592224385 |
ACVRL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1592224402 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1592224412 |
ACVRL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1592225036 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1592225044 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1592225112 |
ACVRL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Telangiectasia, hereditary hemorrhagic |
| RS1592225374 |
DPAGT1
|
Health Risk |
Conflicting classifications of pathogenicity |
DPAGT1-congenital disorder of glycosylation, Congenital myasthenic syndrome 13 |
| RS1592227238 |
DRC2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 27, Primary ciliary dyskinesia 27 |
| RS1592228303 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1592230091 |
COL2A1
|
Health Risk |
Pathogenic |
Retinal detachment, Retinal detachment |
| RS1592232040 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1592232116 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS1592233968 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS1592235124 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Stickler syndrome, Stickler syndrome |
| RS1592235212 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1592235241 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Stickler syndrome type 1, COL2A1-related disorder |
| RS1592238899 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1592252556 |
WNT10B
|
Health Risk |
Likely pathogenic |
Split hand-foot malformation 6, Split hand-foot malformation 6 |
| RS1592257435 |
WNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type III, Osteogenesis imperfecta type III |
| RS1592257820 |
WNT1
|
Health Risk |
Likely pathogenic |
— |
| RS1592259391 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Lissencephaly due to TUBA1A mutation, Lissencephaly due to TUBA1A mutation |
| RS1592260393 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Lissencephaly due to TUBA1A mutation, Lissencephaly due to TUBA1A mutation |
| RS1592264179 |
KRT1
|
Health Risk |
Likely pathogenic |
— |
| RS1592270989 |
CHD4
|
Health Risk |
Likely pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS1592273770 |
CHD4
|
Health Risk |
Likely pathogenic |
— |
| RS1592273799 |
CHD4
|
Health Risk |
Likely pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS1592280796 |
CDKN1B
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia type 4, Multiple endocrine neoplasia type 4 |
| RS1592280833 |
CDKN1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia type 4 |
| RS1592280877 |
CDKN1B
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1592280948 |
CDKN1B
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia type 4, Multiple endocrine neoplasia type 4 |
| RS1592280992 |
CDKN1B
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia type 4, Multiple endocrine neoplasia type 4 |
| RS1592281087 |
CDKN1B
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia type 4 |
| RS1592281257 |
CDKN1B
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia type 4, Multiple endocrine neoplasia type 4 |
| RS1592281716 |
CDKN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia type 4 |
| RS1592283787 |
CNTN1
|
Health Risk |
Pathogenic |
Compton-North congenital myopathy, Compton-North congenital myopathy |
| RS1592289150 |
SMARCD1
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 11, Coffin-Siris syndrome 11 |
| RS1592294569 |
SMARCD1
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 11, Coffin-Siris syndrome 11 |
| RS1592295890 |
SMARCD1
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 11, Coffin-Siris syndrome 11 |
| RS1592295914 |
SMARCD1
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 11, Coffin-Siris syndrome 11 |
| RS1592303371 |
GPD1
|
Health Risk |
Likely pathogenic |
Transient infantile hypertriglyceridemia and hepatosteatosis, Transient infantile hypertriglyceridemia and hepatosteatosis |
| RS1592324196 |
SMARCC2
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 8, Coffin-Siris syndrome 8 |
| RS1592338256 |
PRIM1
|
Health Risk |
Likely pathogenic |
— |
| RS1592341222 |
ALG9
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1592348310 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592348542 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592348901 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592349567 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592350160 |
PAX6
|
Health Risk |
Likely pathogenic |
— |
| RS1592350356 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592350883 |
TBK1
|
Health Risk |
Pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 |
| RS1592350887 |
TBK1
|
Health Risk |
Pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 |
| RS1592354614 |
CEP164
|
Health Risk |
Likely pathogenic |
— |
| RS1592362719 |
TBK1
|
Health Risk |
Pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Amyotrophic lateral sclerosis |
| RS1592366898 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1592367444 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592367623 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592369407 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592369500 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592369895 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592370052 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592370265 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592371840 |
RASGRP2
|
Health Risk |
Likely pathogenic |
Abnormal platelet aggregation, Abnormal bleeding |
| RS1592372097 |
RASGRP2
|
Health Risk |
Likely pathogenic |
Abnormal platelet aggregation, Abnormal platelet aggregation |
| RS1592372480 |
RASGRP2
|
Health Risk |
Likely pathogenic |
Abnormal platelet aggregation, Abnormal platelet aggregation |
| RS1592378730 |
RASGRP2
|
Health Risk |
Likely pathogenic |
Abnormal platelet aggregation, Abnormal platelet aggregation |
| RS1592379014 |
RASGRP2
|
Health Risk |
Likely pathogenic |
Abnormal platelet aggregation, Abnormal platelet aggregation |
| RS1592380672 |
SCN8A
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1592380687 |
SCN8A
|
Health Risk |
Likely pathogenic |
Cognitive impairment with or without cerebellar ataxia, Seizures |
| RS1592380699 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cognitive impairment with or without cerebellar ataxia, Seizures |
| RS1592380743 |
SLC11A2
|
Health Risk |
Pathogenic |
Microcytic anemia with liver iron overload, SLC11A2-related disorder |
| RS1592380834 |
SCN8A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Developmental and epileptic encephalopathy |
| RS1592380859 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1592384832 |
RASGRP2
|
Health Risk |
Pathogenic |
Platelet-type bleeding disorder 18, Platelet-type bleeding disorder 18 |
| RS1592387849 |
SCN8A
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita, Fetal akinesia deformation sequence 1 |
| RS1592387932 |
FGD4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1592389210 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial infantile |
| RS1592390511 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cognitive impairment with or without cerebellar ataxia, Developmental and epileptic encephalopathy |
| RS1592392873 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizure, Intellectual disability |
| RS1592400784 |
CBL
|
Health Risk |
Pathogenic |
CBL-related disorder, Acute myeloid leukemia |
| RS1592400852 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, RASopathy |